MEDIVATION TECHNOLOGIES LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for MEDIVATION TECHNOLOGIES LLC.The latest application filed is for "compounds and methods of use".

Company Profile

15.24.14

MEDIVATION TECHNOLOGIES LLC - New York NY
MEDIVATION TECHNOLOGIES LLC - SAN FRANCISCO CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) Grant 11,364,241 - Wang , et al. June 21, 2	2022-06-21
Compounds and Methods of Use App 20220000847 - Rai; Roopa ; et al.	2022-01-06
Compounds and methods of use Grant 11,053,216 - Rai , et al. July 6, 2	2021-07-06
Coformer Salts Of (2s,3s)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1h-1,2,4-triazol-5-yl)-4-oxo-1,2,- 3,4-tetrahydroquinoline-5-carboxylate And Methods Of Preparing Them App 20210094930 - HENDERSON; Mark ; et al.	2021-04-01
Dihydropyridophthalazinone Inhibitors Of Poly(adp-ribose)polymerase (parp) App 20210069191 - WANG; Bing ; et al.	2021-03-11
Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) Grant 10,780,088 - Wang , et al. Sept	2020-09-22
Dihydropyridophthalazinone Inhibitors Of Poly(adp-ribose)polymerase (parp) App 20200261454 - WANG; Bing ; et al.	2020-08-20
Compounds and Methods of Use App 20200071296 - Rai; Roopa ; et al.	2020-03-05
Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) Grant 10,543,209 - Wang , et al. Ja	2020-01-28
Compounds and methods of use Grant 10,501,436 - Rai , et al. Dec	2019-12-10
Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency Grant 10,493,078 - Chu , et al. De	2019-12-03
Coformer Salts Of (2s,3s)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1h-1,2,4-triazol-5-yl)-4-oxo-1,2,- 3,4-tetrahydroquinoline-5-carboxylate And Methods Of Preparing Them App 20190106401 - HENDERSON; Mark ; et al.	2019-04-11
Dihydropyridophthalazinone Inhibitors Of Poly(adp-ribose)polymerase (parp) For Use In Treatment Of Diseases Associated With A Pten Deficiency App 20190070189 - CHU; Daniel ; et al.	2019-03-07
Treatment Of Small Cell Lung Cancer With A Parp Inhibitor App 20190054087 - FENG; Ying ; et al.	2019-02-21
Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,- 9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt Grant 10,189,837 - Wang , et al. Ja	2019-01-29
Heterocyclic compounds and methods of use Grant 10,189,826 - Pujala , et al. Ja	2019-01-29
Heterocyclic compounds and methods of use Grant 10,183,015 - Bernales , et al. Ja	2019-01-22
Combination Therapy with Apalutamide App 20180228790 - GIBBONS; Jacqueline ; et al.	2018-08-16
Compounds and Methods of Use App 20180208577 - Rai; Roopa ; et al.	2018-07-26
Compounds and methods of use Grant 10,030,004 - Rai , et al. July 24, 2	2018-07-24
Dihydropyridophthalazinone Inhibitors Of Poly(adp-ribose)polymerase (parp) App 20180117045 - WANG; Bing ; et al.	2018-05-03
Processes of synthesizing dihydropyridophthalazinone derivatives Grant 9,926,303 - Wang , et al. March 27, 2	2018-03-27
Heterocyclic Compounds and Methods of Use App 20180051013 - Pujala; Brahmam ; et al.	2018-02-22
Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) Grant 9,820,985 - Wang , et al. November 21, 2	2017-11-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.